Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Liquidia Corp (NQ: LQDA )

6.100 -0.130 (-2.09%)
Streaming Delayed Price Updated: 10:20 AM EDT, Oct 3, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 51,204
Open 6.190
Bid (Size) 6.100 (5)
Ask (Size) 6.130 (1)
Prev. Close 6.230
Today's Range 6.075 - 6.190
52wk Range 4.350 - 9.950
Shares Outstanding 64,741,096
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Emergent BioSolutions Names Two Pharmaceutical Industry Veterans to Board of Directors
From Emergent BioSolutions
Via GlobeNewswire
FDA Accepts Submission to Add PH-ILD to YUTREPIA™ Label
From Liquidia Corporation
Via GlobeNewswire

Performance

YTD
+0.16%
+0.16%
1 Month
-12.73%
-12.73%
3 Month
-22.04%
-22.04%
6 Month
-13.35%
-13.35%
1 Year
+10.51%
+10.51%

More News

Read More
United Therapeutics Corporation Files Lawsuit Alleging Infringement of Tyvaso Patent Already Found to Be Invalid by U.S. Patent Office
From Liquidia Corporation
Via GlobeNewswire
United Therapeutics: A Strong Quarter But What About 2024?
Via Talk Markets
What 5 Analyst Ratings Have To Say About Liquidia
Via Benzinga
Preview: Liquidia's Earnings
Via Benzinga
Why Maxeon Solar Technologies Are Trading Lower By Around 32%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Via Benzinga
Topics Bankruptcy
Exposures Financial Legal
Liquidia Corporation Reports Second Quarter 2023 Financial Results and Provides Corporate Update
From Liquidia Corporation
Via GlobeNewswire
Where Liquidia Stands With Analysts
Via Benzinga
Where Liquidia Stands With Analysts
Via Benzinga
Liquidia: Q1 Earnings Insights
Via Benzinga
Earnings Scheduled For August 10, 2023
Via Benzinga
Earnings Outlook For Liquidia
Via Benzinga
Liquidia Corporation to Report Second Quarter 2023 Financial Results on August 10, 2023
From Liquidia Corporation
Via GlobeNewswire
Liquidia Submits Amendment to Add PH-ILD Indication to Tentatively Approved NDA for YUTREPIA™ (treprostinil) Inhalation Powder
From Liquidia Corporation
Via GlobeNewswire
U.S. Federal Circuit Affirms All District Court Rulings in Patent Litigation
From Liquidia Corporation
Via GlobeNewswire
Why Ryanair Holdings Shares Are Trading Lower By 8%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Via Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
BioXcel Therapeutics, Alvotech And Other Big Stocks Moving Lower On Thursday
Via Benzinga
Why Franklin Covey Shares Are Trading Higher By 25%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Via Benzinga
Liquidia Corporation and Pharmosa Biopharm Announce Collaboration for Sustained-Release Inhaled Treprostinil Product in North America
From Liquidia Corporation
Via GlobeNewswire
Liquidia Corporation to Present at the 2023 Jefferies Healthcare Conference
From Liquidia Corporation
Via GlobeNewswire
Hero or Zero? 7 High-Risk Stocks to Make You Rich… Or Broke.
Via InvestorPlace
Liquidia Announces Poster Presentation at the 2023 American Thoracic Society International Conference
From Liquidia Corporation
Via GlobeNewswire
Liquidia Corporation Reports First Quarter 2023 Financial Results and Provides Corporate Update
From Liquidia Corporation
Via GlobeNewswire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.